These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28431520)
1. Infectious agents is a risk factor for myxomatous mitral valve degeneration: A case control study. Tiveron MG; Pomerantzeff PMA; de Lourdes Higuchi M; Reis MM; de Jesus Pereira J; Kawakami JT; Ikegami RN; de Almeida Brandao CM; Jatene FB BMC Infect Dis; 2017 Apr; 17(1):297. PubMed ID: 28431520 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cytomegalovirus, and Epstein-Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumatic stenotic mitral valves by polymerase chain reaction. Bayram A; Erdoğan MB; Ekşi F; Yamak B Anadolu Kardiyol Derg; 2011 May; 11(3):237-43. PubMed ID: 21466993 [TBL] [Abstract][Full Text] [Related]
3. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Rabkin E; Aikawa M; Stone JR; Fukumoto Y; Libby P; Schoen FJ Circulation; 2001 Nov; 104(21):2525-32. PubMed ID: 11714645 [TBL] [Abstract][Full Text] [Related]
4. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Barth PJ; Köster H; Moosdorf R Pathol Res Pract; 2005; 201(4):301-4. PubMed ID: 15991836 [TBL] [Abstract][Full Text] [Related]
5. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease. Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101 [TBL] [Abstract][Full Text] [Related]
6. Recurrent incompetence of repaired floppy mitral valves and the severity of myxomatous degeneration. Nakayama M; Yutani C; Imakita M; Ishibashi-Ueda H; Nishida N; Kosakai Y; Nakajima N Surg Today; 2000; 30(6):497-502. PubMed ID: 10883458 [TBL] [Abstract][Full Text] [Related]
7. Infectious agents, inflammation, and growth factors: how do they interact in the progression or stabilization of mild human atherosclerotic lesions? Góis J; Higuchi M; Reis M; Diament J; Sousa J; Ramires J; Oliveira S Ann Vasc Surg; 2006 Sep; 20(5):638-45. PubMed ID: 16983590 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome. Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435 [TBL] [Abstract][Full Text] [Related]
9. Mycoplasma pneumoniae and Chlamydia pneumoniae in calcified nodules of aortic stenotic valves. Higuchi Mde L; Higuchi-Dos-Santos MH; Pierri H; Palomino S; Sambiase NV; Ramires JA; Wajngarten M Rev Inst Med Trop Sao Paulo; 2002; 44(4):209-12. PubMed ID: 12219112 [TBL] [Abstract][Full Text] [Related]
10. Co-infection ratios versus inflammation, growth factors and progression of early atheromas. Higuchi ML; Góis JM; Reis MM; Higuchi-Dos-Santos MH; Diament J; Sousa JM; Ramires JA; Oliveira SA APMIS; 2006 May; 114(5):338-44. PubMed ID: 16725009 [TBL] [Abstract][Full Text] [Related]
11. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease. Hulin A; Moore V; James JM; Yutzey KE Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701 [TBL] [Abstract][Full Text] [Related]
12. [Chlamydia pneumoniae and Mycoplasma pneumoniae in calcified nodes of stenosed aortic valves]. Higuchi-Dos-Santos MH; Pierri H; Higuchi Mde L; Nussbacher A; Palomino S; Sambiase NV; Ramires JA; Wajngarten M Arq Bras Cardiol; 2005 Jun; 84(6):443-8. PubMed ID: 16007307 [TBL] [Abstract][Full Text] [Related]
13. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Gupta V; Barzilla JE; Mendez JS; Stephens EH; Lee EL; Collard CD; Laucirica R; Weigel PH; Grande-Allen KJ Cardiovasc Pathol; 2009; 18(4):191-7. PubMed ID: 18621549 [TBL] [Abstract][Full Text] [Related]
14. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms. Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823 [TBL] [Abstract][Full Text] [Related]
15. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease. Mahimkar R; Nguyen A; Mann M; Yeh CC; Zhu BQ; Karliner JS; Lovett DH Cardiovasc Pathol; 2009; 18(5):253-61. PubMed ID: 18835790 [TBL] [Abstract][Full Text] [Related]
16. Cardiac arrhythmias in adolescents with mitral valve prolapse and myxomatous degeneration of mitral valve leaflets. Osovska NY; Kuzminova NV; Knyazkova II Wiad Lek; 2016; 69(6):730-733. PubMed ID: 28214804 [TBL] [Abstract][Full Text] [Related]
18. Mitral Valve Endocarditis: A Rare Manifestation of Lyme Disease. Haddad O; Gillinov M; Fraser T; Shrestha N; Pettersson GB Ann Thorac Surg; 2019 Aug; 108(2):e85-e86. PubMed ID: 30690018 [TBL] [Abstract][Full Text] [Related]
19. Pathology of myxomatous mitral valve disease in the dog. Fox PR J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587 [TBL] [Abstract][Full Text] [Related]
20. Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms. Pires LJ; Gutierrez PS Rev Bras Cir Cardiovasc; 2007; 22(3):322-31. PubMed ID: 18157418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]